Fluoxetine hydrochloride
USP/1279804 - United States Pharmacopeia (USP) Reference Standard
Synonym: (±)-N-Methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; LY-110,140 hydrochloride; Prozac®
CAS Number: 56296-78-7
Empirical Formula (Hill Notation): C17H18F3NO · HCl
Molecular Weight: 345.79
MDL Number: MFCD00214288
Linear Formula: C17H18F3NO · HCl
Product Type: Chemical
| API family | fluoxetine |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C17H18F3NO.ClH/c1-21-1 |
| InChI key | GIYXAJPCNFJEHY-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | CNCCC(C1=CC=CC=C1)OC2=CC= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Fluoxetine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Fluoxetine Tablets • Fluoxetine Delayed-Release Capsules • Olanzapine and Fluoxetine Capsules • Fluoxetine Oral Solution • Fluoxetine Capsules |
| Biochem/physiol Actions: | Selective serotonin reuptake inhibitor; antidepressant. |
| Legal Information: | Prozac is a registered trademark of Eli Lilly and Co. |
| Legal Information: | Sold under license from Eli Lilly and Company. |
| Other Notes: | Sales restrictions may apply. |
| Symbol |     GHS05,GHS07,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H302 - H318 - H336 - H373 - H410 |
| Precautionary statements | P260 - P273 - P280 - P301 + P312 - P305 + P351 + P338 - P314 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |